<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> is a multistage polyclonal disease that is associated with the development of <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> of the esophagus and esophagogastric junction </plain></SENT>
<SENT sid="1" pm="."><plain>Telomerase activation is associated with cellular immortality and <z:e sem="disease" ids="C0596263" disease_type="Neoplastic Process" abbrv="">carcinogenesis</z:e>, and increased expression of the telomerase reverse transcriptase catalytic subunit (hTERT) has been used for the early detection of malignant diseases </plain></SENT>
<SENT sid="2" pm="."><plain>To identify biomarkers associated with each stage of the Barrett's process, relative <z:chebi fb="2" ids="33699">mRNA</z:chebi> expression levels of hTERT were measured using a quantitative reverse transcription-polymerase chain reaction method (ABI 7700 Sequence Detector (TaqMan system) in Barrett's <z:mpath ids='MPATH_167'>intestinal metaplasia</z:mpath> (n = 14), Barrett's <z:mpath ids='MPATH_589'>dysplasia</z:mpath> (n = 10), Barrett's <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> (n = 14), and matching <z:mpath ids='MPATH_458'>normal</z:mpath> squamous esophagus tissues (n = 32) </plain></SENT>
<SENT sid="3" pm="."><plain>hTERT expression was significantly increased at <z:hpo ids='HP_0000001'>all</z:hpo> stages of <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo>, including the <z:mpath ids='MPATH_167'>intestinal metaplasia</z:mpath> stage, compared to <z:mpath ids='MPATH_458'>normal</z:mpath> tissues from patients without <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> (<z:mpath ids='MPATH_167'>intestinal metaplasia</z:mpath> vs. <z:mpath ids='MPATH_458'>normal</z:mpath> esophagus, P &lt;0.0001; <z:mpath ids='MPATH_589'>dysplasia</z:mpath>, P = 0.001; <z:mp ids='MP_0009308'>adenocarcinoma</z:mp>, P = 0.007; <z:hpo ids='HP_0000001'>all</z:hpo> Mann-Whitney U test ) </plain></SENT>
<SENT sid="4" pm="."><plain>hTERT expression levels were significantly higher in <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> tissues than in <z:mpath ids='MPATH_167'>intestinal metaplasia</z:mpath> tissues (P = 0.003), and were higher in <z:mpath ids='MPATH_589'>dysplasia</z:mpath> compared with <z:mpath ids='MPATH_167'>intestinal metaplasia</z:mpath> tissues (P = 0.056) </plain></SENT>
<SENT sid="5" pm="."><plain>hTERT levels were also significantly higher in histologically <z:mpath ids='MPATH_458'>normal</z:mpath> squamous esophagus tissues from <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> patients than in <z:mpath ids='MPATH_458'>normal</z:mpath> esophagus tissues from patients with no <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> (P = 0.013) </plain></SENT>
<SENT sid="6" pm="."><plain>Very high expression levels ([hTERT x 100: beta-actin] &gt;20) were found only in patients with <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> </plain></SENT>
<SENT sid="7" pm="."><plain>These findings suggest that telomerase activation is an important early event in the development of <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> and esophageal <z:mp ids='MP_0009308'>adenocarcinoma</z:mp>, that very high telomerase levels may be a clinically useful biomarker for the detection of occult <z:mp ids='MP_0009308'>adenocarcinoma</z:mp>, and that a widespread <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> "field" effect is present in the esophagus of patients with Barrett's <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> </plain></SENT>
</text></document>